Publications by authors named "Judith Carser"

Claim this Profile
C
Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma: A UK Real-World Evidence Study.
Anna Olsson-Brown, Ankit Jain, Ricky Frazer, David Farrugia, Judith Carser

Oncol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF mutant advanced melanoma (INTERIM).
Alimu Dayimu, Avinash Gupta, Rubeta N Matin, Jenny Nobes, Ruth Board, Judith Carser

Eur J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of tacrolimus in the management of checkpoint inhibitor immunotherapy-induced hepatitis.
Stuart McIlwaine, Anna Cullen, Leanne Stratton, Bode Oladipo, Johnny Cash, Judith Carser

J R Coll Physicians Edinb· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients.
Richard Baird, Ian Banks, David Cameron, John Chester, Helena Earl, Judith Carser

Ecancermedicalscience· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.
Judith E Carser, Jennifer E Quinn, Caroline O Michie, Eamonn J O'Brien, W Glenn McCluggage

Gynecol Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 and implications for response to chemotherapy in ovarian cancer.
Jennifer E Quinn, Judith E Carser, Colin R James, Richard D Kennedy, D Paul Harkin

Gynecol Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer.
Judith Elizabeth Carser, Yvonne Jane Summers

J Thorac Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis